A transforming mutation in the pleckstrin homology domain of AKT1 in cancer (original) (raw)

• Vivanco, I. & Sawyers, C. L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nature Rev. Cancer 2, 489–501 (2002)
  Article CAS Google Scholar
• Ahmed, N. N. et al. The proteins encoded by c_-akt_ and v_-akt_ differ in post-translational modification, subcellular localization and oncogenic potential. Oncogene 8, 1957–1963 (1993)
  CAS PubMed Google Scholar
• Bachman, K. E. et al. The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol. Ther. 3, 772–775 (2004)
  Article CAS PubMed Google Scholar
• Campbell, I. G. et al. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res. 64, 7678–7681 (2004)
  Article CAS PubMed Google Scholar
• Lee, J. W. et al. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene 24, 1477–1480 (2005)
  Article CAS PubMed Google Scholar
• Levine, D. A. et al. Frequent mutation of the PIK3CA gene in ovarian and breast cancers. Clin. Cancer Res. 11, 2875–2878 (2005)
  Article ADS CAS PubMed Google Scholar
• Saal, L. H. et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res. 65, 2554–2559 (2005)
  Article CAS PubMed Google Scholar
• Samuels, Y. et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 304, 554 (2004)
  Article CAS PubMed Google Scholar
• Cantley, L. C. & Neel, B. G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl Acad. Sci. USA 96, 4240–4245 (1999)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Khan, S. et al. PTEN promoter is methylated in a proportion of invasive breast cancers. Int. J. Cancer 112, 407–410 (2004)
  Article CAS PubMed Google Scholar
• Cantley, L. C. The phosphoinositide 3-kinase pathway. Science 296, 1655–1657 (2002)
  Article ADS CAS PubMed Google Scholar
• Stocker, H. et al. Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB. Science 295, 2088–2091 (2002)
  Article ADS CAS PubMed Google Scholar
• Fukuda, M., Kojima, T., Kabayama, H. & Mikoshiba, K. Mutation of the pleckstrin homology domain of Bruton’s tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity. J. Biol. Chem. 271, 30303–30306 (1996)
  Article CAS PubMed Google Scholar
• Franke, T. F. et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81, 727–736 (1995)
  Article CAS PubMed Google Scholar
• Li, W., Zhu, T. & Guan, K. L. Transformation potential of Ras isoforms correlates with activation of phosphatidylinositol 3-kinase but not ERK. J. Biol. Chem. 279, 37398–37406 (2004)
  Article CAS PubMed Google Scholar
• Andjelkovic, M. et al. Role of translocation in the activation and function of protein kinase B. J. Biol. Chem. 272, 31515–31524 (1997)
  Article CAS PubMed Google Scholar
• Mirza, A. M., Kohn, A. D., Roth, R. A. & McMahon, M. Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB. Cell Growth Differ. 11, 279–292 (2000)
  CAS PubMed Google Scholar
• Sun, M. et al. AKT1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am. J. Pathol. 159, 431–437 (2001)
  Article CAS PubMed PubMed Central Google Scholar
• Sjoblom, T. et al. The consensus coding sequences of human breast and colorectal cancers. Science 314, 268–274 (2006)
  Article ADS PubMed Google Scholar
• Milburn, C. C. et al. Binding of phosphatidylinositol 3,4,5-trisphosphate to the pleckstrin homology domain of protein kinase B induces a conformational change. Biochem. J. 375, 531–538 (2003)
  Article CAS PubMed PubMed Central Google Scholar
• Thomas, C. C., Deak, M., Alessi, D. R. & van Aalten, D. M. High-resolution structure of the pleckstrin homology domain of protein kinase B/Akt bound to phosphatidylinositol (3,4,5)-trisphosphate. Curr. Biol. 12, 1256–1262 (2002)
  Article CAS PubMed Google Scholar
• Komander, D. et al. Structural insights into the regulation of PDK1 by phosphoinositides and inositol phosphates. EMBO J. 23, 3918–3928 (2004)
  Article CAS PubMed PubMed Central Google Scholar
• Franke, T. F., Kaplan, D. R., Cantley, L. C. & Toker, A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275, 665–668 (1997)
  Article CAS PubMed Google Scholar
• Klippel, A., Kavanaugh, W. M., Pot, D. & Williams, L. T. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol. Cell. Biol. 17, 338–344 (1997)
  Article CAS PubMed PubMed Central Google Scholar
• Stephens, L. et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279, 710–714 (1998)
  Article ADS CAS PubMed Google Scholar
• Barnett, S. F. et al. Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors. Biochem. J. 385, 399–408 (2005)
  Article CAS PubMed PubMed Central Google Scholar
• Watton, S. J. & Downward, J. Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell–matrix and cell–cell interaction. Curr. Biol. 9, 433–436 (1999)
  Article CAS PubMed Google Scholar
• Scheid, M. P., Marignani, P. A. & Woodgett, J. R. Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B. Mol. Cell. Biol. 22, 6247–6260 (2002)
  Article CAS PubMed PubMed Central Google Scholar
• Adams, J. M. et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318, 533–538 (1985)
  Article ADS CAS PubMed Google Scholar
• Wendel, H. G. et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428, 332–337 (2004)
  Article ADS CAS PubMed Google Scholar
• Adams, J. M. & Cory, S. Transgenic models for haemopoietic malignancies. Biochim. Biophys. Acta 1072, 9–31 (1991)
  CAS PubMed Google Scholar
• Altomare, D. A. & Testa, J. R. Perturbations of the AKT signaling pathway in human cancer. Oncogene 24, 7455–7464 (2005)
  Article CAS PubMed Google Scholar
• Parsons, D. W. et al. Colorectal cancer: mutations in a signalling pathway. Nature 436, 792 (2005)
  Article ADS CAS PubMed Google Scholar
• Staal, S. P. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc. Natl Acad. Sci. USA 84, 5034–5037 (1987)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Knobbe, C. B. & Reifenberger, G. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3′-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol. 13, 507–518 (2003)
  Article CAS PubMed Google Scholar
• Soung, Y. H. et al. Mutational analysis of AKT1, AKT2 and AKT3 genes in common human carcinomas. Oncology 70, 285–289 (2006)
  Article CAS PubMed Google Scholar
• Hawley, R. G. et al. Versatile vectors for potential use in gene therapy. Gene Ther. 1, 136–138 (1994)
  CAS PubMed Google Scholar